Table 2.
Ethnic/racial Differences in History of Weight Loss Treatment Utilization among Patients with Obesity and Binge-eating Disorder
| Diet | Overall Sample (n=400) |
Non- Hispanic Black (n=99) |
Hispanic (n=38) |
Non- Hispanic White (n=263) |
Racemain effect | Post-hocs | ||
|---|---|---|---|---|---|---|---|---|
| n (%) | Diet (M±SD) n (%) |
Diet (M±SD) n (%) |
Diet (M±SD) n (%) |
χ2(2) (p) | H vs. B1 OR (95% CI) |
W vs. B1 OR (95% CI) |
W vs. H1 OR (95% CI) |
|
| Self-help | 10.2±37.2 | 21.7±69.6 | 25.6±60.3 | 15.7 (.0004) | 2.2 (1.0, 4.7)* | 2.5 (1.6, 4.0)*** | 1.1 (0.6, 2.3) | |
| 0 times | 44 (11.9) | 18 (19.8) | 4 (12.5) | 22 (8.9) | ||||
| 1-2 times | 90 (24.4) | 32 (35.2) | 9 (28.1) | 49 (19.9) | ||||
| 3-4 times | 44 (11.9) | 9 (9.9) | 2 (6.3) | 33 (13.4) | ||||
| 5+ times | 191 (51.8) | 32 (35.2) | 17 (53.1) | 142 (57.7) | ||||
| Fad/crash | 4.1 ±10.3 | 4.8 ±17.5 | 6.2 ±19.5 | 0.5 (0.8) | 1.3 (0.6, 2.8) | 1.1 (0.7, 1.8) | 0.9 (0.4, 1.8) | |
| 0 times | 178 (48.2) | 45 (50.0) | 16 (50.0) | 117 (47.4) | ||||
| 1-2 times | 84 (22.8) | 23 (25.6) | 6 (18.8) | 55 (22.3) | ||||
| 3-4 times | 34 (9.2) | 8 (8.9) | 5 (15.6) | 21 (8.5) | ||||
| 5+ times | 73 (19.8) | 14 (15.6) | 5 (15.6) | 54 (21.9) | ||||
| Supervised Diets | 2.0 ±5.5 | 2.5 ±5.0 | 5.4 ±12.7 | 46.9 (< .0001) | 1.7 (0.8, 3.9) | 5.5 (3.3, 9.2) *** | 3.2 (1.5, 6.6)** | |
| 0 times | 128 (34.6) | 52 (57.8) | 18 (54.6) | 58 (23.5) | ||||
| 1-2 times | 110 (29.7) | 24 (26.7) | 6 (18.2) | 80 (32.4) | ||||
| 3-4 times | 44 (11.9) | 6 (6.7) | 3 (9.1) | 35 (14.2) | ||||
| 5+ times | 88 (23.8) | 8 (8.9) | 6 (18.2) | 74 (30.0) | ||||
| Prescribed Meds | 0.4 ±1.2 | 0.4 ±1.3 | 0.5 ±1.6 | 0.9 (0.6) | 0.8 (0.3, 2.4) | 1.2 (0.7, 2.2) | 1.5 (0.6, 4.1) | |
| 0 times | 284 (76.8) | 70 (77.8) | 28 (84.9) | 186 (75.3) | ||||
| 1-2 times | 72 (19.5) | 18 (20.0) | 3 (9.1) | 51 (20.7) | ||||
| 3-4 times | 7 (1.9) | 1 (1.1) | 1 (3.0) | 5 (2.0) | ||||
| 5+ times | 7 (1.9) | 1 (1.1) | 1 (3.0) | 5 (2.0) | ||||
| Nutritionist-led | 0.5 ±1.3 | 0.6±0.9 | 0.8±2.2 | 2.7 (0.3) | 2.0 (0.9, 4.5) | 1.1 (0.7, 1.9) | 0.6 (0.3, 1.2) | |
| 0 times | 240 (64.7) | 62 (68.9) | 19 (57.6) | 159 (64.1) | ||||
| 1-2 times | 110 (29.7) | 24 (26.7) | 12 (36.4) | 74 (29.8) | ||||
| 3-4 times | 15 (4.0) | 3 (3.3) | 2 (6.1) | 10 (4.0) | ||||
| 5+ times | 6 (1.6) | 1 (1.1) | 0 (0.0) | 5 (2.0) | ||||
| Mental health | 0.1 ±0.4 | 0.1 ±0.2 | 0.2 ±0.5 | 4.3 (0.1) | 2.3 (0.4, 14.8) | 3.6 (1.1, 12.0) | 1.5 (0.3, 7.0) | |
| 0 times | 335 (90.5) | 87 (96.7) | 31 (93.9) | 217 (87.9) | ||||
| 1-2 times | 32 (8.7) | 2 (2.2) | 2 (6.1) | 28 (11.3) | ||||
| 3-4 times | 3 (0.8) | 1 (1.1) | 0 (0.0) | 2 (0.8) | ||||
| 5+ times | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||||
| OTC Meds | 5.3 ±12.8 | 3.9 ±12.4 | 3.6 ±9.3 | 1.6 (0.5) | 0.5 (0.2, 1.5) | 0.8 (0.4, 1.5) | 1.6 (0.6, 4.5) | |
| 0 times | 121 (50.0) | 17 (39.5) | 9 (56.3) | 95 (51.9) | ||||
| 1-2 times | 64 (26.5) | 15 (34.9) | 5 (31.3) | 44 (24.0) | ||||
| 3-4 times | 17 (7.0) | 3 (7.0) | 0 (0.0) | 14 (7.7) | ||||
| 5+ times | 40 (16.5) | 8 (18.6) | 2 (12.5) | 30 (16.4) | ||||
Note: All analyses adjusted for age and sex
*
p<.05
**
p≤.01
***
p≤.001; in the post hoc columns
1
signifies the reference group; OTC meds = over the counter medications; analyses based on log transformed data; n’s listed in the table represent the subset of participants who utilized the various treatment options